1-(3-bromophenyl)cyclopropan-1-amine;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]carbamate;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]-N-methylcarbamate;tert-butyl N-methyl-N-[1-(3-methylphenyl)cyclopropyl]carbamate;tert-butyl 3-[methyl-[1-(3-methylphenyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tert-butyl 3-[methyl-(1-phenylcyclopropyl)carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tetrakis(carbon dioxide);N-methyl-1-(3-methylphenyl)cyclopropan-1-amine
C114H144Br3N13O20 — CID 165063025
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(3-bromophenyl)cyclopropan-1-amine;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]carbamate;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]-N-methylcarbamate;tert-butyl N-methyl-N-[1-(3-methylphenyl)cyclopropyl]carbamate;tert-butyl 3-[methyl-[1-(3-methylphenyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tert-butyl 3-[methyl-(1-phenylcyclopropyl)carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tetrakis(carbon dioxide);N-methyl-1-(3-methylphenyl)cyclopropan-1-amine
1-(3-bromophenyl)cyclopropan-1-amine;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]carbamate;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]-N-methylcarbamate;tert-butyl N-methyl-N-[1-(3-methylphenyl)cyclopropyl]carbamate;tert-butyl 3-[methyl-[1-(3-methylphenyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tert-butyl 3-[methyl-(1-phenylcyclopropyl)carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tetrakis(carbon dioxide);N-methyl-1-(3-methylphenyl)cyclopropan-1-amine (PubChem CID 165063025) has the molecular formula C114H144Br3N13O20 and a molecular weight of 2256.19 g/mol. Its IUPAC name is 1-(3-bromophenyl)cyclopropan-1-amine;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]carbamate;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]-N-methylcarbamate;tert-butyl N-methyl-N-[1-(3-methylphenyl)cyclopropyl]carbamate;tert-butyl 3-[methyl-[1-(3-methylphenyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tert-butyl 3-[methyl-(1-phenylcyclopropyl)carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tetrakis(carbon dioxide);N-methyl-1-(3-methylphenyl)cyclopropan-1-amine.
Molecular Properties
| Compound Name | 1-(3-bromophenyl)cyclopropan-1-amine;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]carbamate;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]-N-methylcarbamate;tert-butyl N-methyl-N-[1-(3-methylphenyl)cyclopropyl]carbamate;tert-butyl 3-[methyl-[1-(3-methylphenyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tert-butyl 3-[methyl-(1-phenylcyclopropyl)carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tetrakis(carbon dioxide);N-methyl-1-(3-methylphenyl)cyclopropan-1-amine |
|---|---|
| PubChem CID | 165063025 |
| Molecular Formula | C114H144Br3N13O20 |
| Molecular Weight | 2256.19 g/mol |
| Exact Mass | 2251.82 |
| IUPAC Name | 1-(3-bromophenyl)cyclopropan-1-amine;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]carbamate;tert-butyl N-[1-(3-bromophenyl)cyclopropyl]-N-methylcarbamate;tert-butyl N-methyl-N-[1-(3-methylphenyl)cyclopropyl]carbamate;tert-butyl 3-[methyl-[1-(3-methylphenyl)cyclopropyl]carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tert-butyl 3-[methyl-(1-phenylcyclopropyl)carbamoyl]-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate;tetrakis(carbon dioxide);N-methyl-1-(3-methylphenyl)cyclopropan-1-amine |
| SMILES | CC(C)(C)OC(=O)NC1(c2cccc(Br)c2)CC1.CN(C(=O)OC(C)(C)C)C1(c2cccc(Br)c2)CC1.CN(C(=O)c1cnn2c1CN(C(=O)OC(C)(C)C)CC2)C1(c2ccccc2)CC1.CNC1(c2cccc(C)c2)CC1.Cc1cccc(C2(N(C)C(=O)OC(C)(C)C)CC2)c1.Cc1cccc(C2(N(C)C(=O)c3cnn4c3CN(C(=O)OC(C)(C)C)CC4)CC2)c1.NC1(c2cccc(Br)c2)CC1.O=C=O.O=C=O.O=C=O.O=C=O |
| InChI | InChI=1S/C23H30N4O3.C22H28N4O3.C16H23NO2.C15H20BrNO2.C14H18BrNO2.C11H15N.C9H10BrN.4CO2/c1-16-7-6-8-17(13-16)23(9-10-23)25(5)20(28)18-14-24-27-12-11-26(15-19(18)27)21(29)30-22(2,3)4;1-21(2,3)29-20(28)25-12-13-26-18(15-25)17(14-23-26)19(27)24(4)22(10-11-22)16-8-6-5-7-9-16;1-12-7-6-8-13(11-12)16(9-10-16)17(5)14(18)19-15(2,3)4;1-14(2,3)19-13(18)17(4)15(8-9-15)11-6-5-7-12(16)10-11;1-13(2,3)18-12(17)16-14(7-8-14)10-5-4-6-11(15)9-10;1-9-4-3-5-10(8-9)11(12-2)6-7-11;10-8-3-1-2-7(6-8)9(11)4-5-9;4*2-1-3/h6-8,13-14H,9-12,15H2,1-5H3;5-9,14H,10-13,15H2,1-4H3;6-8,11H,9-10H2,1-5H3;5-7,10H,8-9H2,1-4H3;4-6,9H,7-8H2,1-3H3,(H,16,17);3-5,8,12H,6-7H2,1-2H3;1-3,6H,4-5,11H2;;;; |
| InChIKey | RNBFYYWSNMBBHU-UHFFFAOYSA-N |
| XLogP | 21.48 |
| TPSA | 407.36 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 150 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2256.19 |
| LogP ≤ 5 | 21.48 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 26 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 165063025 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.